{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T21:34:09Z","timestamp":1774301649916,"version":"3.50.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Natural Science Foundation of Guangxi","award":["2025GXNSFAA069044"],"award-info":[{"award-number":["2025GXNSFAA069044"]}]},{"name":"The Natural Science Foundation of Guangxi","award":["2025GXNSFBA069574"],"award-info":[{"award-number":["2025GXNSFBA069574"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12010-025-05528-2","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T03:17:00Z","timestamp":1767496620000},"page":"1591-1618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated Multi-Omics Analysis Reveals Cytokine Network Dynamics and Prognostic Signatures in Hepatitis B Virus-Associated Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"198","author":[{"given":"Mo-Han","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin-Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-Liao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,4]]},"reference":[{"issue":"12","key":"5528_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal, A. G., Kanwal, F., & Llovet, J. M. (2023). Global trends in hepatocellular carcinoma epidemiology: Implications for screening, prevention and therapy. Nature Reviews. Clinical Oncology, 20(12), 864\u2013884.","journal-title":"Nature Reviews. Clinical Oncology"},{"issue":"3","key":"5528_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F., Laversanne, M., Sung, H., et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. C Ca: A Cancer Journal for Clinicians, 74(3), 229\u2013263.","journal-title":"C Ca: A Cancer Journal for Clinicians"},{"issue":"2","key":"5528_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/ijms22020479","volume":"22","author":"V Pandyarajan","year":"2021","unstructured":"Pandyarajan, V., Govalan, R., & Yang, J. D. (2021). Risk factors and biomarkers for chronic hepatitis B associated hepatocellular carcinoma. International Journal of Molecular Sciences, 22(2), 479.","journal-title":"International Journal of Molecular Sciences"},{"issue":"10360","key":"5528_CR4","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel, A., Meyer, T., Sapisochin, G., Salem, R., & Saborowski, A. (2022). Hepatocellular carcinoma. Lancet, 400(10360), 1345\u20131362.","journal-title":"Lancet"},{"key":"5528_CR5","doi-asserted-by":"publisher","first-page":"1188277","DOI":"10.3389\/fimmu.2023.1188277","volume":"14","author":"M Zhao","year":"2023","unstructured":"Zhao, M., Huang, H., He, F., & Fu, X. (2023). Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma. Frontiers in Immunology, 14, 1188277.","journal-title":"Frontiers in Immunology"},{"key":"5528_CR6","doi-asserted-by":"publisher","first-page":"1472430","DOI":"10.3389\/fimmu.2024.1472430","volume":"15","author":"MN Khan","year":"2024","unstructured":"Khan, M. N., Mao, B., Hu, J., et al. (2024). Tumor-associated macrophages and CD8\u2009+\u2009T cells: Dual players in the pathogenesis of HBV-related HCC. Frontiers in Immunology, 15, 1472430.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"5528_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12943-024-02183-9","volume":"23","author":"H Wang","year":"2024","unstructured":"Wang, H., Wang, T., Yan, S., et al. (2024). Crosstalk of pyroptosis and cytokine in the tumor microenvironment: From mechanisms to clinical implication. Molecular Cancer, 23(1), 268.","journal-title":"Molecular Cancer"},{"key":"5528_CR8","doi-asserted-by":"publisher","first-page":"156442","DOI":"10.1016\/j.cyto.2023.156442","volume":"173","author":"L Xiao","year":"2024","unstructured":"Xiao, L., Tang, K., Fu, T., et al. (2024). Cytokine profiles and virological markers highlight distinctive immune statuses, and effectivenesses and limitations of NAs across different courses of chronic HBV infection. Cytokine, 173, 156442.","journal-title":"Cytokine"},{"issue":"1","key":"5528_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02325-5","volume":"10","author":"J Xu","year":"2025","unstructured":"Xu, J., Ding, L., Mei, J., et al. (2025). Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Signal Transduction and Targeted Therapy, 10(1), Article 268.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"5528_CR10","doi-asserted-by":"publisher","first-page":"1572764","DOI":"10.3389\/fimmu.2025.1572764","volume":"16","author":"M Xiao","year":"2025","unstructured":"Xiao, M., & Li, X. (2025). The impact of the tumor microenvironment on macrophages. Frontiers in Immunology, 16, 1572764.","journal-title":"Frontiers in Immunology"},{"key":"5528_CR11","doi-asserted-by":"crossref","unstructured":"GrantG, & FerrerCM (2025). The role of the immune tumor microenvironment in shaping metastatic dissemination, dormancy, and outgrowth. Trends in Cell Biology, S0962\u201389242500124 [pii].","DOI":"10.1016\/j.tcb.2025.05.006"},{"issue":"1","key":"5528_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail, M., Jiang, C. H., & Li, N. (2025). Immune evasion in cancer: Mechanisms and cutting-edge therapeutic approaches. Signal Transduction and Targeted Therapy, 10(1), Article 227.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"5528_CR13","doi-asserted-by":"crossref","unstructured":"Yu, Y., Cui, X., Zhao, J., Jia, T., Ren, B., & Zhang, X. (2021). Effect of entecavir combined with adefovir dipivoxil on clinical efficacy and TNF-\u03b1 and IL-6 levels in patients with hepatitis B cirrhosis. J Oncol, 2021: 9162346.","DOI":"10.1155\/2021\/9162346"},{"key":"5528_CR14","doi-asserted-by":"publisher","first-page":"1024333","DOI":"10.3389\/fimmu.2022.1024333","volume":"13","author":"M Li","year":"2022","unstructured":"Li, M., Gao, Y., Yang, L., et al. (2022). Dynamic changes of cytokine profiles and virological markers during 48 weeks of Entecavir treatment for HBeAg-positive chronic hepatitis B. Frontiers in Immunology, 13, 1024333.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"5528_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s43046-024-00238-y","volume":"36","author":"EH Abuelnadar","year":"2024","unstructured":"Abuelnadar, E. H., Ramadan, L. M., Shahin, H. E., et al. (2024). Association of IL-6 G-174\u00a0C (rs1800795) variant with the susceptibility to hepatocellular carcinoma in patients with chronic hepatitis. Journal of the Egyptian National Cancer Institute, 36(1), 32.","journal-title":"Journal of the Egyptian National Cancer Institute"},{"key":"5528_CR16","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3389\/fimmu.2020.00849","volume":"11","author":"P Fisicaro","year":"2020","unstructured":"Fisicaro, P., Barili, V., Rossi, M., et al. (2020). Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches. Frontiers in Immunology, 11, 849.","journal-title":"Frontiers in Immunology"},{"key":"5528_CR17","doi-asserted-by":"crossref","unstructured":"Tan, N. H., Chen, B., Peng, J., & Du, S. (2021). Treg\/Th17 cell balance in patients with hepatitis B virus-related acute-on-chronic liver failure at different disease stages. Biomed Res Int, 9140602.","DOI":"10.1155\/2021\/9140602"},{"issue":"1","key":"5528_CR18","doi-asserted-by":"publisher","first-page":"12084","DOI":"10.1038\/s41598-022-16341-w","volume":"12","author":"X Liu","year":"2022","unstructured":"Liu, X., Xiao, C., Yue, K., Chen, M., Zhou, H., & Yan, X. (2022). Identification of multi-omics biomarkers and construction of the novel prognostic model for hepatocellular carcinoma. Scientific Reports, 12(1), 12084.","journal-title":"Scientific Reports"},{"issue":"12","key":"5528_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101315","volume":"4","author":"X Xing","year":"2023","unstructured":"Xing, X., Hu, E., Ouyang, J., et al. (2023). Integrated omics landscape of hepatocellular carcinoma suggests proteomic subtypes for precision therapy. Cell Reports Medicine, 4(12), Article 101315.","journal-title":"Cell Reports Medicine"},{"key":"5528_CR20","doi-asserted-by":"publisher","first-page":"1517312","DOI":"10.3389\/fimmu.2024.1517312","volume":"15","author":"S Li","year":"2024","unstructured":"Li, S., Lin, Y., Gao, X., et al. (2024). Integrative multi-omics analysis reveals a novel subtype of hepatocellular carcinoma with biological and clinical relevance. Frontiers in Immunology, 15, 1517312.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"5528_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-01010-8","volume":"9","author":"W Wen","year":"2025","unstructured":"Wen, W., & Wang, R. (2025). Consensus artificial intelligence-driven prognostic signature for predicting the prognosis of hepatocellular carcinoma: A multi-center and large-scale study. NPJ Precision Oncology, 9(1), Article 207.","journal-title":"NPJ Precision Oncology"},{"key":"5528_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1420353","volume":"11","author":"Y Li","year":"2024","unstructured":"Li, Y., Fang, Y., Li, D., et al. (2024). Constructing a prognostic model for hepatocellular carcinoma based on bioinformatics analysis of inflammation-related genes. Frontiers in Medicine, 11, Article 1420353.","journal-title":"Frontiers in Medicine"},{"key":"5528_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvr.2023.200271","volume":"16","author":"S Zhang","year":"2023","unstructured":"Zhang, S., Jiang, C., Jiang, L., et al. (2023). Construction of a diagnostic model for hepatitis B-related hepatocellular carcinoma using machine learning and artificial neural networks and revealing the correlation by immunoassay. Tumour Virus Research, 16, Article 200271.","journal-title":"Tumour Virus Research"},{"issue":"2","key":"5528_CR24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2214829120","volume":"120","author":"M Qu","year":"2023","unstructured":"Qu, M., Zhang, G., Qu, H., et al. (2023). Circadian regulator BMAL1: : CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle. Proceedings of the National Academy of Sciences of the United States of America, 120(2), Article e2214829120.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"5528_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.livres.2025.09.002","volume":"9","author":"M Linlin","year":"2025","unstructured":"Linlin, M., Shuzhen, C., Hongyang, W., & Lei, C. (2025). Hepatitis B virus integration and hepatocarcinogenesis. Liver Research, 9(3), 189\u2013198.","journal-title":"Liver Research"},{"issue":"3","key":"5528_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/0115665232274223231017052707","volume":"24","author":"J Wang","year":"2024","unstructured":"Wang, J., Sun, L., Liu, Y., & Zhang, Y. (2024). FIGNL1 promotes hepatocellular carcinoma formation via remodeling ECM-receptor interaction pathway mediated by HMMR. Current Gene Therapy, 24(3), 249\u2013263.","journal-title":"Current Gene Therapy"},{"key":"5528_CR27","doi-asserted-by":"publisher","first-page":"1421195","DOI":"10.3389\/fcimb.2024.1421195","volume":"14","author":"J Chen","year":"2024","unstructured":"Chen, J., Yin, Q., Xu, S., et al. (2024). IFN-treated macrophage-derived exosomes prevents HBV-HCC migration and invasion via regulating miR-106b-3p\/PCGF3\/PI3K\/AKT signaling axis. Frontiers in Cellular and Infection Microbiology, 14, 1421195.","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"issue":"2","key":"5528_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202402080","volume":"22","author":"M Rafe Hatshan","year":"2025","unstructured":"Rafe Hatshan, M., Perianaika Matharasi Antonyraj, A., Marunganathan, V., et al. (2025). Synergistic action of vanillic acid-coated titanium oxide nanoparticles: Targeting biofilm formation receptors of dental pathogens and modulating apoptosis genes for enhanced oral anticancer activity. Chemistry & Biodiversity, 22(2), Article e202402080.","journal-title":"Chemistry & Biodiversity"},{"issue":"1","key":"5528_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00859-2","volume":"29","author":"CL Kuo","year":"2022","unstructured":"Kuo, C. L., Ponneri Babuharisankar, A., Lin, Y. C., et al. (2022). Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: Foe or friend. Journal of Biomedical Science, 29(1), Article 74.","journal-title":"Journal of Biomedical Science"},{"issue":"3","key":"5528_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202401961","volume":"22","author":"M Rafi Shaik","year":"2025","unstructured":"Rafi Shaik, M., Ramasamy, M., Jain, D., et al. (2025). Dual action of nanostructured \u03b1-mangostin-copper oxide complexes against dental pathogen biofilms and oral cancer via apoptosis gene modulation. Chemistry & Biodiversity, 22(3), Article e202401961.","journal-title":"Chemistry & Biodiversity"},{"issue":"7","key":"5528_CR31","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3390\/microorganisms10071265","volume":"10","author":"GL Popa","year":"2022","unstructured":"Popa, G. L., & Popa, M. I. (2022). Oxidative stress in chronic hepatitis B-an update. Microorganisms, 10(7), 1265.","journal-title":"Microorganisms"},{"issue":"7","key":"5528_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202403415","volume":"22","author":"P Nainangu","year":"2025","unstructured":"Nainangu, P., K, K., Subramanian, K., Gopal, S., & Antonyraj, A. (2025). Characterization of bioactive metabolites in Phormidium sp. PB21: Pigment production, antimicrobial potential, and toxicity assessment. Chemistry & Biodiversity, 22(7), Article e202403415.","journal-title":"Chemistry & Biodiversity"},{"issue":"1","key":"5528_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-024-00580-9","volume":"19","author":"Y Jia","year":"2024","unstructured":"Jia, Y., Jiao, X., Shi, W., et al. (2024). Expression of 10 circulating cytokines\/chemokines in HBV-related liver disease. Infectious Agents and Cancer, 19(1), Article 20.","journal-title":"Infectious Agents and Cancer"},{"issue":"1","key":"5528_CR34","first-page":"32","volume":"113","author":"B Lucke-Wold 3rd","year":"2017","unstructured":"Lucke-Wold, B. 3rd, Bonasso, P. C., Turner, R., & Cassim, R. (2017). Adenocarcinoma of the cecum with rare Splenic metastasis. West Virginia Medical Journal, 113(1), 32\u201334.","journal-title":"West Virginia Medical Journal"},{"issue":"9","key":"5528_CR35","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1158\/0008-5472.CAN-20-3453","volume":"81","author":"C Zhang","year":"2021","unstructured":"Zhang, C., Gao, Y., Du, C., et al. (2021). Hepatitis B-induced IL8 promotes hepatocellular carcinoma venous metastasis and intrahepatic Treg accumulation. Cancer Research, 81(9), 2386\u20132398.","journal-title":"Cancer Research"},{"issue":"1","key":"5528_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12894-024-01569-7","volume":"24","author":"S Babadi","year":"2024","unstructured":"Babadi, S., Shahri, M. M., Nematollahi, S. F., et al. (2024). Relationship between NLR and penile squamous cell carcinoma: A systematic review and meta-analysis. BMC Urology, 24(1), 194.","journal-title":"BMC Urology"},{"key":"5528_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.805625","volume":"8","author":"S Zhong","year":"2021","unstructured":"Zhong, S., Zhang, T., Tang, L., & Li, Y. (2021). Cytokines and chemokines in HBV infection. Frontiers in Molecular Biosciences, 8, Article 805625.","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"4","key":"5528_CR38","doi-asserted-by":"publisher","first-page":"e0306823","DOI":"10.1128\/mbio.03068-23","volume":"15","author":"J Tang","year":"2024","unstructured":"Tang, J., Zhang, J., Zhang, G., et al. (2024). Stat3 activation-triggered transcriptional networks govern the early stage of HBV-induced hepatic inflammation. mBio, 15(4), e0306823.","journal-title":"mBio"},{"key":"5528_CR39","doi-asserted-by":"publisher","first-page":"217278","DOI":"10.1016\/j.canlet.2024.217278","volume":"605","author":"X Gu","year":"2024","unstructured":"Gu, X., Li, D., Wu, P., et al. (2024). Revisiting the CXCL13\/CXCR5 axis in the tumor microenvironment in the era of single-cell omics: Implications for immunotherapy. Cancer Letters, 605, 217278.","journal-title":"Cancer Letters"},{"issue":"2","key":"5528_CR40","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1053\/j.gastro.2017.04.021","volume":"153","author":"SM Laidlaw","year":"2017","unstructured":"Laidlaw, S. M., Marukian, S., Gilmore, R. H., et al. (2017). Tumor necrosis factor inhibits spread of hepatitis C virus among liver cells, independent from interferons. Gastroenterology, 153(2), 566-578e5.","journal-title":"Gastroenterology"},{"key":"5528_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.655697","volume":"12","author":"J Giraud","year":"2021","unstructured":"Giraud, J., Chalopin, D., Blanc, J., & Saleh, M. (2021). Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies. Frontiers in Immunology, 12, Article 655697.","journal-title":"Frontiers in Immunology"},{"key":"5528_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/bs.acr.2020.12.002","volume":"149","author":"C Fountzilas","year":"2021","unstructured":"Fountzilas, C., Evans, R., Alaklabi, S., & Iyer, R. (2021). Immunotherapy in hepatocellular cancer. Advances in Cancer Research, 149, 295\u2013320.","journal-title":"Advances in Cancer Research"},{"key":"5528_CR43","doi-asserted-by":"publisher","first-page":"944088","DOI":"10.3389\/fphar.2022.944088","volume":"13","author":"G Shao","year":"2022","unstructured":"Shao, G., Liu, Y., Lu, L., et al. (2022). The pathogenesis of HCC driven by NASH and the preventive and therapeutic effects of natural products. Frontiers in Pharmacology, 13, 944088.","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"5528_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s13679-023-00519-y","volume":"12","author":"ID Vachliotis","year":"2023","unstructured":"Vachliotis, I. D., & Polyzos, S. A. (2023). The role of tumor necrosis factor-alpha in the pathogenesis and treatment of nonalcoholic fatty liver disease. Current Obesity Reports, 12(3), 191\u2013206.","journal-title":"Current Obesity Reports"},{"issue":"7854","key":"5528_CR45","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","volume":"592","author":"D Pfister","year":"2021","unstructured":"Pfister, D., N\u00fa\u00f1ez, N. G., Pinyol, R., et al. (2021). NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature, 592(7854), 450\u2013456.","journal-title":"Nature"},{"issue":"10","key":"5528_CR46","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41423-024-01199-x","volume":"21","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Chen, W., Qiao, S., et al. (2024). Lipid droplet accumulation mediates macrophage survival and Treg recruitment via the CCL20\/CCR6 axis in human hepatocellular carcinoma. Cellular and Molecular Immunology, 21(10), 1120\u20131130.","journal-title":"Cellular and Molecular Immunology"},{"key":"5528_CR47","unstructured":"Lu, Y., Liu, Y., Zuo, X. (2024). CXCL12(+) Tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma. Journal of Hepatology,\u00a0\u00a0S0168-8278(24)02618-7 [pii]."},{"issue":"2","key":"5528_CR48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3350\/cmh.2020.0247","volume":"27","author":"CC Lin","year":"2021","unstructured":"Lin, C. C., Liu, T. W., Yeh, M. L., et al. (2021). Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognostic factor in hepatitis C virus-related hepatocellular carcinoma. Clinical and Molecular Hepatology, 27(2), 313\u2013328.","journal-title":"Clinical and Molecular Hepatology"},{"key":"5528_CR49","doi-asserted-by":"publisher","first-page":"1411161","DOI":"10.3389\/fimmu.2024.1411161","volume":"15","author":"J Tian","year":"2024","unstructured":"Tian, J., Meng, J., Yang, Z., Song, L., Jiang, X., & Zou, J. (2024). Hepatitis B-related hepatocellular carcinoma: Classification and prognostic model based on programmed cell death genes. Frontiers in Immunology, 15, 1411161.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"5528_CR50","doi-asserted-by":"publisher","first-page":"26038","DOI":"10.1038\/s41598-025-10876-4","volume":"15","author":"Y Zhong","year":"2025","unstructured":"Zhong, Y., Stalin, A., Dai, Y., et al. (2025). Integrating bulk and single cell sequencing data to identify prognostic biomarkers and drug candidates in HBV associated hepatocellular carcinoma. Scientific Reports, 15(1), 26038.","journal-title":"Scientific Reports"},{"issue":"15","key":"5528_CR51","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.3390\/ijms21155186","volume":"21","author":"S Kadomoto","year":"2020","unstructured":"Kadomoto, S., Izumi, K., & Mizokami, A. (2020). The CCL20-CCR6 axis in cancer progression. International Journal of Molecular Sciences, 21(15), 5186.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"5528_CR52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12935-025-03765-3","volume":"25","author":"Y Lv","year":"2025","unstructured":"Lv, Y., Chen, C., Han, M., et al. (2025). CXCL2: A key player in the tumor microenvironment and inflammatory diseases. Cancer Cell International, 25(1), 133.","journal-title":"Cancer Cell International"},{"issue":"1","key":"5528_CR53","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/imm.13462","volume":"166","author":"A Zarezadeh Mehrabadi","year":"2022","unstructured":"Zarezadeh Mehrabadi, A., Aghamohamadi, N., Khoshmirsafa, M., et al. (2022). The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions. Immunology, 166(1), 38\u201346.","journal-title":"Immunology"},{"issue":"4","key":"5528_CR54","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.gendis.2021.04.003","volume":"9","author":"S Viswanadhapalli","year":"2022","unstructured":"Viswanadhapalli, S., Dileep, K. V., Zhang, K., Nair, H. B., & Vadlamudi, R. K. (2022). Targeting LIF\/LIFR signaling in cancer. Genes & Diseases, 9(4), 973\u2013980.","journal-title":"Genes & Diseases"},{"issue":"5","key":"5528_CR55","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41574-021-00471-8","volume":"17","author":"P Morigny","year":"2021","unstructured":"Morigny, P., Boucher, J., Arner, P., & Langin, D. (2021). Lipid and glucose metabolism in white adipocytes: Pathways, dysfunction and therapeutics. Nature Reviews. Endocrinology, 17(5), 276\u2013295.","journal-title":"Nature Reviews. Endocrinology"},{"issue":"2","key":"5528_CR56","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s42255-018-0021-8","volume":"1","author":"ET Chouchani","year":"2019","unstructured":"Chouchani, E. T., & Kajimura, S. (2019). Metabolic adaptation and maladaptation in adipose tissue. Nature Metabolism, 1(2), 189\u2013200.","journal-title":"Nature Metabolism"},{"key":"5528_CR57","doi-asserted-by":"publisher","first-page":"1086604","DOI":"10.3389\/fonc.2023.1086604","volume":"13","author":"Z He","year":"2023","unstructured":"He, Z., Chen, Q., He, W., et al. (2023). Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets. Frontiers in Oncology, 13, 1086604.","journal-title":"Frontiers in Oncology"},{"key":"5528_CR58","doi-asserted-by":"publisher","first-page":"1019638","DOI":"10.3389\/fimmu.2022.1019638","volume":"13","author":"Q Wang","year":"2022","unstructured":"Wang, Q., Qiao, W., Zhang, H., et al. (2022). Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma. Frontiers in Immunology, 13, 1019638.","journal-title":"Frontiers in Immunology"},{"issue":"45","key":"5528_CR59","volume":"11","author":"S Yin","year":"2024","unstructured":"Yin, S., Li, C., Shen, X., et al. (2024). Siglec-G suppresses CD8(+) T cells responses through metabolic rewiring and can be targeted to enhance tumor immunotherapy. Advanced Science (Weinheim), 11(45), Article e2403438.","journal-title":"Advanced Science (Weinheim)"},{"issue":"7967","key":"5528_CR60","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41586-023-06199-x","volume":"618","author":"B Kruse","year":"2023","unstructured":"Kruse, B., Buzzai, A. C., Shridhar, N., et al. (2023). CD4(+) T cell-induced inflammatory cell death controls immune-evasive tumours. Nature, 618(7967), 1033\u20131040.","journal-title":"Nature"},{"issue":"19","key":"5528_CR61","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1016\/j.cell.2023.07.034","volume":"186","author":"F Tang","year":"2023","unstructured":"Tang, F., Li, J., Qi, L., et al. (2023). A pan-cancer single-cell panorama of human natural killer cells. Cell, 186(19), 4235\u20134251e20.","journal-title":"Cell"},{"issue":"8046","key":"5528_CR62","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41586-024-08257-4","volume":"637","author":"A Elewaut","year":"2025","unstructured":"Elewaut, A., Estivill, G., Bayerl, F., et al. (2025). Cancer cells impair monocyte-mediated T cell stimulation to evade immunity. Nature, 637(8046), 716\u2013725.","journal-title":"Nature"},{"issue":"15","key":"5528_CR63","doi-asserted-by":"publisher","first-page":"12375","DOI":"10.3390\/ijms241512375","volume":"24","author":"Y Huang","year":"2023","unstructured":"Huang, Y., Fan, Y., Zhao, Z., et al. (2023). Inhibition of CDK1 by RO-3306 exhibits anti-tumorigenic effects in ovarian cancer cells and a transgenic mouse model of ovarian cancer. International Journal of Molecular Sciences, 24(15), 12375.","journal-title":"International Journal of Molecular Sciences"},{"key":"5528_CR64","doi-asserted-by":"publisher","first-page":"139893","DOI":"10.1016\/j.ijbiomac.2025.139893","volume":"297","author":"Q Chen","year":"2025","unstructured":"Chen, Q., Lu, C., Li, D., Xu, L., Wang, C., & Yu, L. (2025). CDK1 inhibitor RO-3306 enhances BTKi potency in diffuse large B-cell lymphoma by suppressing JAK2\/STAT3 signaling. International Journal of Biological Macromolecules, 297, 139893.","journal-title":"International Journal of Biological Macromolecules"},{"issue":"1","key":"5528_CR65","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-00860-1","volume":"15","author":"Q Zhao","year":"2024","unstructured":"Zhao, Q., Yu, M., Li, J., et al. (2024). GLUD1 inhibits hepatocellular carcinoma progression via ROS-mediated p38\/JNK MAPK pathway activation and mitochondrial apoptosis. Discover Oncology, 15(1), Article 8.","journal-title":"Discover Oncology"},{"issue":"1","key":"5528_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01187-4","volume":"14","author":"T Kong","year":"2024","unstructured":"Kong, T., Laranjeira, A., Letson, C. T., et al. (2024). RSK1 dependency in FLT3-ITD acute myeloid leukemia. Blood Cancer Journal, 14(1), Article 207.","journal-title":"Blood Cancer Journal"},{"issue":"3","key":"5528_CR67","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/cac2.12527","volume":"44","author":"S Zhang","year":"2024","unstructured":"Zhang, S., Jia, X., Dai, H., et al. (2024). SERPINE2 promotes liver cancer metastasis by inhibiting c-Cbl-mediated EGFR ubiquitination and degradation. Cancer Communications, 44(3), 384\u2013407.","journal-title":"Cancer Communications"},{"issue":"7","key":"5528_CR68","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3390\/ijms18071447","volume":"18","author":"Y Takahashi","year":"2017","unstructured":"Takahashi, Y. (2017). The role of growth hormone and Insulin-Like growth factor-I in the liver. International Journal of Molecular Sciences, 18(7), 1447.","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"5528_CR69","doi-asserted-by":"publisher","DOI":"10.1097\/IN9.0000000000000030","volume":"5","author":"IL Ma","year":"2023","unstructured":"Ma, I. L., & Stanley, T. L. (2023). Growth hormone and nonalcoholic fatty liver disease. Immunometabolism, 5(3), Article e00030.","journal-title":"Immunometabolism"},{"issue":"10","key":"5528_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102478","volume":"13","author":"GN Tzanakakis","year":"2021","unstructured":"Tzanakakis, G. N., Giatagana, E. M., Berdiaki, A., et al. (2021). The role of IGF\/IGF-IR-signaling and extracellular matrix effectors in bone sarcoma pathogenesis. Cancers (Basel), 13(10), Article 2478.","journal-title":"Cancers (Basel)"},{"key":"5528_CR71","doi-asserted-by":"crossref","unstructured":"Sueki, A., Kaya, D., Nagamatsu, S. (2024). A case of secondary growth hormone deficiency that developed into cirrhosis after several years of interrupted growth hormone replacement therapy. Internal Medicine.","DOI":"10.2169\/internalmedicine.3896-24"},{"issue":"19","key":"5528_CR72","doi-asserted-by":"publisher","first-page":"11188","DOI":"10.3390\/ijms231911188","volume":"23","author":"A Kasprzak","year":"2022","unstructured":"Kasprzak, A., & Adamek, A. (2022). Role of the Ghrelin system in colitis and hepatitis as risk factors for inflammatory-related cancers. International Journal of Molecular Sciences, 23(19), 11188.","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"5528_CR73","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/cells12040517","volume":"12","author":"L Cristin","year":"2023","unstructured":"Cristin, L., Montini, A., Martinino, A., Scarano Pereira, J. P., Giovinazzo, F., & Agnes, S. (2023). The role of growth hormone and insulin growth factor 1 in the development of non-alcoholic steato-hepatitis: A systematic review. Cells, 12(4), 517.","journal-title":"Cells"},{"key":"5528_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.836080","volume":"9","author":"D Cai","year":"2022","unstructured":"Cai, D., Zhao, Z., Hu, J., et al. (2022). Identification of the tumor immune microenvironment and therapeutic biomarkers by a novel molecular subtype based on aging-related genes in hepatocellular carcinoma. Frontiers in Surgery, 9, Article 836080.","journal-title":"Frontiers in Surgery"},{"issue":"15","key":"5528_CR75","doi-asserted-by":"publisher","first-page":"13955","DOI":"10.1007\/s00432-023-05178-z","volume":"149","author":"A Yuemaierabola","year":"2023","unstructured":"Yuemaierabola, A., Guo, J., Sun, L., et al. (2023). Comprehensive analysis of CPSF4-related alternative splice genes in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology, 149(15), 13955\u201313971.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"11","key":"5528_CR76","doi-asserted-by":"publisher","first-page":"e0277266","DOI":"10.1371\/journal.pone.0277266","volume":"17","author":"MA Abu El-Makarem","year":"2022","unstructured":"Abu El-Makarem, M. A., Kamel, M. F., Mohamed, A. A., et al. (2022). Down-regulation of hepatic expression of GHR\/STAT5\/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 and type 2 transforming growth factor-beta receptor. PLoS One, 17(11), e0277266.","journal-title":"PLoS One"},{"issue":"2","key":"5528_CR77","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1139\/bcb-2021-0386","volume":"100","author":"Y Meng","year":"2022","unstructured":"Meng, Y., Zhou, B., Pei, Z., Chen, Y., & Chang, D. (2022). The nuclear-localized GHR is involved in the cell proliferation of gastric cancer, and Pegvisomant may be an important potential drug to inhibit the proliferation of gastric cancer cells. Biochemistry and Cell Biology, 100(2), 125\u2013135.","journal-title":"Biochemistry and Cell Biology"},{"issue":"18","key":"5528_CR78","doi-asserted-by":"publisher","first-page":"18127","DOI":"10.18632\/aging.103625","volume":"12","author":"S Gao","year":"2020","unstructured":"Gao, S., Ni, Q., Wu, X., & Cao, T. (2020). GHR knockdown enhances the sensitivity of HCC cells to Sorafenib. Aging (Albany NY), 12(18), 18127\u201318136.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"5528_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01934-w","volume":"9","author":"Y Lv","year":"2024","unstructured":"Lv, Y., Qi, J., Babon, J. J., et al. (2024). The JAK-STAT pathway: From structural biology to cytokine engineering. Signal Transduction and Targeted Therapy, 9(1), Article 221.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"3","key":"5528_CR80","first-page":"179","volume":"39","author":"G Di Bella","year":"2018","unstructured":"Di Bella, G., Colori, B., & Scanferlato, R. (2018). The over-expression of GH\/GHR in tumour tissues with respect to healthy ones confirms its oncogenic role and the consequent oncosuppressor role of its physiological inhibitor, somatostatin: A review of the literature. Neuroendocrinology Letters, 39(3), 179\u2013188.","journal-title":"Neuroendocrinology Letters"},{"issue":"13","key":"5528_CR81","doi-asserted-by":"publisher","first-page":"21579","DOI":"10.18632\/oncotarget.15375","volume":"8","author":"R Basu","year":"2017","unstructured":"Basu, R., Wu, S., & Kopchick, J. J. (2017). Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways. Oncotarget, 8(13), 21579\u201321598.","journal-title":"Oncotarget"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05528-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-025-05528-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05528-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T21:03:12Z","timestamp":1773781392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-025-05528-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,4]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["5528"],"URL":"https:\/\/doi.org\/10.1007\/s12010-025-05528-2","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,4]]},"assertion":[{"value":"10 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (approval number: 2024-E660-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}